We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,497
Closed
1,027

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBFX
4526
DELISTED
PBF LOGISTICS LP
PBFX
-891
Closed -$19K
JEMD
4527
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
-31
Closed
ZEN
4528
DELISTED
ZENDESK INC
ZEN
-835
Closed -$71K
GBL
4529
DELISTED
GAMCO Investors, Inc.
GBL
-2,841
Closed -$58K
AMPE
4530
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-19
Closed -$3K
GCP
4531
DELISTED
GCP Applied Technologies Inc.
GCP
-1,725
Closed -$51K
MANT
4532
DELISTED
Mantech International Corp
MANT
-74
Closed -$4K
CTT
4533
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
-6,375
Closed -$63K
ALJJ
4534
DELISTED
ALJ Regional Holdings Inc
ALJJ
-1,306
Closed -$2K
ATHX
4535
DELISTED
Athersys, Inc. Common Stock
ATHX
-191
Closed -$7K
SMED
4536
DELISTED
Sharps Compliance Corp
SMED
-50
Closed
RDUS
4537
DELISTED
Radius Health, Inc.
RDUS
-100
Closed -$2K
EPZM
4538
DELISTED
Epizyme, Inc
EPZM
-246
Closed -$3K
OBCI
4539
DELISTED
Ocean Bio-Chem Inc
OBCI
$0 ﹤0.01%
100
-185
-65% -$596
NPTN
4540
DELISTED
NEOPHOTONICS CORP
NPTN
-13,282
Closed -$84K
WBT
4541
DELISTED
Welbilt, Inc.
WBT
-3,774
Closed -$62K
XELA
4542
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
-$6K
MIC
4543
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
-10
Closed
MBII
4544
DELISTED
Marrone Bio Innovations, Inc.
MBII
-8,247
Closed -$12K
SRRA
4545
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-146
Closed -$10K
TREC
4546
DELISTED
Trecora Resources
TREC
-1,693
Closed -$15K
PLAN
4547
DELISTED
Anaplan, Inc.
PLAN
-11
Closed
STRDW
4548
DELISTED
Sitio Royalties Corp. Warrant
STRDW
$0 ﹤0.01%
248
IRCP
4549
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
-1,293
Closed -$6K
VWTR
4550
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
-705
Closed -$7K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,027 positions and reducing 1,497 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,027 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.